ADC Therapeutics
John Iorio has over 19 years of experience in external reporting and corporate accounting. Currently serving as Senior Manager of External Reporting at ADC Therapeutics since September 2020, John previously held the position of Senior Manager - Corporate Accounting at Celgene from June 2017 to September 2020. Prior to that, John worked at Tyco International plc for nearly 14 years, where responsibilities included serving as Manager from November 2003 to June 2017.
This person is not in any offices
ADC Therapeutics
2 followers
ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.